Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.

MRI-guided Radiation Therapy (MRgRT), FLASH proton therapy, concurrent immunotherapy, and radiation therapy and SBRT for oligometastatic disease, are emerging technologies and approaches to optimize cancer care.

Topics Included:1. BrachytherapyParticipants will learn about the radiation therapy modality of brachytherapy. Codes specific to this modality are addressed. ASTRO’s Brachytherapy Model Policy is reviewed in detail.

Topics Included:1. Proton Beam TherapyParticipants will learn about the proton beam therapy (PBT) radiation modality and codes. ASTRO’s Proton Beam Therapy Model Policy is reviewed in detail.